AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33629809 — intervention group
Group type: COMPARATOR
Intervention: EBUS
Number of subjects: 152
Study 33015888 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX
Number of subjects: 690
Study 33015888 — intervention group
Group type: COMPARATOR
Intervention: 5FU
Number of subjects: 690
Study 34057310 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 12
Study 34341040 — intervention group
Group type: EXPERIMENTAL
Intervention: Current aftercare situation for women with GDM
Number of subjects: 0
Study 34341040 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of a patient-centred care model
Number of subjects: 0
Study 34438362 — intervention group
Group type: EXPERIMENTAL
Intervention: Training sessions consisting of 2 ModeA tests per session (30 tests total)
Number of subjects: 24
Study 34438362 — intervention group
Group type: EXPERIMENTAL
Intervention: Retraining sessions after 1 or 2 weeks of detraining
Number of subjects: 24
Study 34438362 — intervention group
Group type: EXPERIMENTAL
Intervention: ModeA test (1-minute reaction time test)
Number of subjects: 24
Study 34193356 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemostatic sealant
Number of subjects: 75
Study 34193356 — intervention group
Group type: COMPARATOR
Intervention: Bipolar diathermy
Number of subjects: 75
Study 34193356 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral lesions
Number of subjects: 75
Study 34193356 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemostatic sealant and Bipolar diathermy
Number of subjects: 75
Study 35687807 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) components (problem solving, changing unhelpful thoughts, relaxation skills)
Number of subjects: 319
Study 35687807 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers (being bullied, difficulty applying therapy content to new situations)
Number of subjects: 319
Study 35687807 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparisons between youth with different anxiety disorder trajectories
Number of subjects: 319
Study 34120366 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate treatment
Number of subjects: 308
Study 34120366 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 308
Study 33755143 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg daily for 48 weeks
Number of subjects: 188
Study 33755143 — intervention group
Group type: COMPARATOR
Intervention: placebo for 48 weeks
Number of subjects: 188
Study 33755143 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin
Number of subjects: 188
Study 33755143 — intervention group
Group type: COMPARATOR
Intervention: linagliptin and placebo
Number of subjects: 188
Study 32692386 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment (25 µg titrated to aim for serum thyrotropin levels between 0.4 and 2.5 mU/L)
Number of subjects: 95
Study 32692386 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical to levothyroxine)
Number of subjects: 95
Study 32692386 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment
Number of subjects: 95
Study 32692386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 35358464 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus pomalidomide and low-dose dexamethasone
Number of subjects: 0
Study 35358464 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide and low-dose dexamethasone
Number of subjects: 0
Study 33338679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ologen collagen matrix (OCM) implantation during AGV surgery
Number of subjects: 26
Study 33338679 — intervention group
Group type: COMPARATOR
Intervention: Control group (AGV surgery without OCM)
Number of subjects: 26
Study 35420334 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (placebo-controlled trial)
Number of subjects: 19114
Study 32873953 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3, 1.68 g)
Number of subjects: 0
Study 32873953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34916444 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg Lycium barbarum polysaccharide (LBP) for 6 weeks
Number of subjects: 29
Study 34916444 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 29
Study 32165040 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard chemotherapy
Number of subjects: 103
Study 32165040 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy at Ben Taub Hospital (BTH)
Number of subjects: 103
Study 32165040 — intervention group
Group type: COMPARATOR
Intervention: Subjects enrolled in the CRYSTAL trial
Number of subjects: 103
Study 35150407 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention-based Long-Short-Term-Memory (LSTM) model for classification of normal/stressed trials
Number of subjects: 30
Study 35150407 — intervention group
Group type: EXPERIMENTAL
Intervention: Second LSTM classifier for distinguishing normal and stressed movements
Number of subjects: 30
Study 35150407 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification of normal and stressed movements in stressed trials
Number of subjects: 30
Study 33755145 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924
Study 33755145 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study 32746574 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctors
Number of subjects: 189
Study 32746574 — intervention group
Group type: COMPARATOR
Intervention: Nurses, pharmacists, laboratory staff, radiology staff, and managers
Number of subjects: 189
Study 32746574 — intervention group
Group type: COMPARATOR
Intervention: Different age groups
Number of subjects: 189
Study 32746574 — intervention group
Group type: COMPARATOR
Intervention: Various dimensions of occupational pressure
Number of subjects: 189
Study 35960704 — intervention group
Group type: EXPERIMENTAL
Intervention: EASE (Early Adolescent Skills for Emotions)
Number of subjects: 471
Study 35960704 — intervention group
Group type: COMPARATOR
Intervention: EUC (Enhanced Usual Care)
Number of subjects: 471
Study 32799841 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral intravenous parenteral nutrition (P-PN)
Number of subjects: 92
Study 35440375 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about interval safety, test accuracy and speed of cell changes
Number of subjects: 2931
Study 35440375 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional messages)
Number of subjects: 2931
Study 35440375 — intervention group
Group type: EXPERIMENTAL
Intervention: Being up‐to‐date with screening and previous abnormal results
Number of subjects: 2931
Study 33886934 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training
Number of subjects: 24
Study 33886934 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 35738551 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + Er, Cr: YSGG laser
Number of subjects: 36
Study 35738551 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + a-PDT (methylene blue mediated antimicrobial photodynamic therapy using 660 nm diode laser)
Number of subjects: 36
Study 35738551 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 36
Study 35791455 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 5.0 mcg
Number of subjects: 105
Study 35791455 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 7.5 mcg
Number of subjects: 105
Study 35791455 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 10.0 mcg
Number of subjects: 105
Study 33151775 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ascorbate (VitC) 2g
Number of subjects: 8
Study 33151775 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo, PL)
Number of subjects: 8
Study 35485814 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio wave electrotherapy (448 kHz)
Number of subjects: 61
Study 35485814 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 61
Study 35127522 — intervention group
Group type: EXPERIMENTAL
Intervention: High OC/OL‐EVOO (40 ml/day, 416 mg/Kg OC and 284 mg/kg OL for 3 months)
Number of subjects: 20
Study 35127522 — intervention group
Group type: EXPERIMENTAL
Intervention: High OC/OL‐EVOO (40 ml/day for 6 months)
Number of subjects: 20
Study 35127522 — intervention group
Group type: COMPARATOR
Intervention: Low OC/OL (40 ml/day, 82 mg/kg OC and 33 mg/kg OL for 3 months)
Number of subjects: 20
Study 35229548 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate peel extract (PoPEx) 250 mg twice daily
Number of subjects: 30
Study 35229548 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules twice daily
Number of subjects: 30
Study 33616555 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% sodium hypochlorite (SH) for 20 minutes
Number of subjects: 45
Study 33616555 — intervention group
Group type: EXPERIMENTAL
Intervention: Efferdent for 3 minutes
Number of subjects: 45
Study 33616555 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.25% Ricinus communis (RC) for 20 minutes
Number of subjects: 45
Study 33616555 — intervention group
Group type: COMPARATOR
Intervention: 0.85% saline solution for 20 minutes (control)
Number of subjects: 45
Study 33616555 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush immersion in solutions (SH, Efferdent, RC)
Number of subjects: 45
Study 33616555 — intervention group
Group type: EXPERIMENTAL
Intervention: SH and Efferdent
Number of subjects: 45
Study 32827035 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcriptome-wide association study (TWAS) for total body BMD (TB-BMD)
Number of subjects: 66
Study 32827035 — intervention group
Group type: EXPERIMENTAL
Intervention: Summarized mendelian randomization analysis
Number of subjects: 66
Study 32827035 — intervention group
Group type: COMPARATOR
Intervention: Previous GWASs or TWASs for osteoporosis
Number of subjects: 66
Study 32827035 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel genes identified
Number of subjects: 66
Study 35241394 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐wk intensive smoking and/or alcohol cessation intervention
Number of subjects: 104
Study 35241394 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 104
Study 33577586 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-stand test (STST)
Number of subjects: 36
Study 33577586 — intervention group
Group type: COMPARATOR
Intervention: Six-minute walk test (6MWT)
Number of subjects: 36
Study 32172681 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based yoga instruction
Number of subjects: 62
Study 32172681 — intervention group
Group type: COMPARATOR
Intervention: Appearance-based yoga instruction
Number of subjects: 62
Study 32172681 — intervention group
Group type: COMPARATOR
Intervention: Neutral yoga instruction
Number of subjects: 62
Study 33971939 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole School SEND Review intervention
Number of subjects: 58000
Study 32638035 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg)
Number of subjects: 65
Study 32638035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 32229610 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic Mendelian Randomization methods
Number of subjects: 0
Study 32229610 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic score as an instrument
Number of subjects: 0
Study 32229610 — intervention group
Group type: EXPERIMENTAL
Intervention: Outlier detection
Number of subjects: 0
Study 32229610 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian approaches
Number of subjects: 0
Study 33243791 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led, screening-Triggered, early specialised palliative care intervention programme
Number of subjects: 206
Study 33243791 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 206
Study 34156129 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 60
Study 34156129 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower oil
Number of subjects: 60
Study 34156129 — intervention group
Group type: EXPERIMENTAL
Intervention: Poultry oil
Number of subjects: 60
Study 34156129 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk thistle meal (30 g/kg)
Number of subjects: 60
Study 34156129 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat powder
Number of subjects: 60
Study 34156129 — intervention group
Group type: EXPERIMENTAL
Intervention: Poultry oil, sunflower oil, fish oil
Number of subjects: 60
Study 34156129 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish or sunflower oil
Number of subjects: 60
Study 34156129 — intervention group
Group type: EXPERIMENTAL
Intervention: Poultry oil and milk thistle meal (30 g/kg)
Number of subjects: 60
Study 34289823 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 50-150 mg BID
Number of subjects: 2742
Study 36333296 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut oral immunotherapy (OIT)
Number of subjects: 120
Study 32271500 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Talk about Children intervention
Number of subjects: 73
Study 36247420 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg a day on top of antidiabetic treatment)
Number of subjects: 110
Study 36247420 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific treatment mentioned)
Number of subjects: 110
Study 36247420 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg a day)
Number of subjects: 110
Study 36247420 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline RDW
Number of subjects: 110
Study 33326024 — intervention group
Group type: EXPERIMENTAL
Intervention: Traffic light system (TLS)-based educational intervention
Number of subjects: 34
Study 33326024 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 34
Study 33555207 — intervention group
Group type: EXPERIMENTAL
Intervention: High Cu hydroxychloride (CHC)
Number of subjects: 1792
Study 33555207 — intervention group
Group type: EXPERIMENTAL
Intervention: High Cu hydroxychloride (CHC) with medium Zn hydroxychloride (ZHC)
Number of subjects: 1792
Study 33555207 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium Zn hydroxychloride (ZHC)
Number of subjects: 1792
Study 33555207 — intervention group
Group type: EXPERIMENTAL
Intervention: High Cu sulphate monohydrate (CSM) with high Zn sulphate monohydrate (ZSM)
Number of subjects: 1792
Study 33555207 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Cu hydroxychloride (CHC) with low or medium Zn hydroxychloride (ZHC)
Number of subjects: 1792
Study 33555207 — intervention group
Group type: EXPERIMENTAL
Intervention: High Cu hydroxychloride (CHC) and low Zn hydroxychloride (ZHC)
Number of subjects: 1792
Study 32306085 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 weeks of balneotherapy (daily whirlpool baths, hydrokinesitherapy sessions, knee shower/massages)
Number of subjects: 120
Study 32306085 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual analgesia medication only)
Number of subjects: 120
Study 35333744 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfaxalone (5 mg/kg)
Number of subjects: 24
Study 35333744 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfaxalone (5 mg/kg) and midazolam (0.5 mg/kg)
Number of subjects: 24
Study 33236087 — intervention group
Group type: EXPERIMENTAL
Intervention: Two randomly selected leaves from the middle stratum
Number of subjects: 140
Study 33236087 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard uppermost + lowermost leaf sample unit (L1+U1)
Number of subjects: 140
Study 33236087 — intervention group
Group type: COMPARATOR
Intervention: Other sample units
Number of subjects: 140
Study 32653577 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 35
Study 32653577 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 35
Study 34881641 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C19 testing
Number of subjects: 0
Study 34090603 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg once daily
Number of subjects: 0
Study 34090603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33177724 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track rehabilitation nursing (study group 1)
Number of subjects: 82
Study 33177724 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track rehabilitation nursing (study group 2)
Number of subjects: 82
Study 33177724 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (control group)
Number of subjects: 82
Study 33177724 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain control (all groups)
Number of subjects: 82
Study 33177724 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with pain control (all groups)
Number of subjects: 82
Study 35871931 — intervention group
Group type: EXPERIMENTAL
Intervention: Intuitive Eating Group (IEG; n=23)
Number of subjects: 58
Study 35871931 — intervention group
Group type: EXPERIMENTAL
Intervention: Intuitive Eating and Nutritional Guidelines Group (IEGDG; n=17)
Number of subjects: 58
Study 35871931 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG; n=18)
Number of subjects: 58
Study 35029099 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layer composite resin teeth (Group 2)
Number of subjects: 20
Study 35029099 — intervention group
Group type: COMPARATOR
Intervention: Conventional composite resin teeth (Group 1)
Number of subjects: 20
Study 35029099 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 20
Study 32707403 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheeled knee walker (WKW)
Number of subjects: 21
Study 32707403 — intervention group
Group type: EXPERIMENTAL
Intervention: Walker
Number of subjects: 21
Study 32707403 — intervention group
Group type: EXPERIMENTAL
Intervention: Crutches
Number of subjects: 21
Study 32707403 — intervention group
Group type: COMPARATOR
Intervention: No assistive device (control condition)
Number of subjects: 21
Study 35614488 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper arm self-sampling device (UA)
Number of subjects: 50
Study 35614488 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger prick-test (FP)
Number of subjects: 50
Study 35614488 — intervention group
Group type: COMPARATOR
Intervention: Venous blood sampling (VBS)
Number of subjects: 50
Study 33822227 — intervention group
Group type: EXPERIMENTAL
Intervention: SO-DCS (anodal suboccipital direct current stimulation)
Number of subjects: 40
Study 33822227 — intervention group
Group type: EXPERIMENTAL
Intervention: M1-DCS (anodal motor cortex direct current stimulation)
Number of subjects: 40
Study 33822227 — intervention group
Group type: COMPARATOR
Intervention: Sham DCS
Number of subjects: 40
Study 33822227 — intervention group
Group type: EXPERIMENTAL
Intervention: SO-DCS and M1-DCS
Number of subjects: 40
Study 34134024 — intervention group
Group type: EXPERIMENTAL
Intervention: ReVeRe.D (iPad-administered cognitive test battery)
Number of subjects: 244
Study 34134024 — intervention group
Group type: COMPARATOR
Intervention: examiner-administered tests
Number of subjects: 244
Study 32067625 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol-based standard care
Number of subjects: 85
Study 32067625 — intervention group
Group type: COMPARATOR
Intervention: Rifaximin and standard care
Number of subjects: 85
Study 36470699 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 36
Study 36470699 — intervention group
Group type: COMPARATOR
Intervention: Control group (noise reduction)
Number of subjects: 36
Study 36470699 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study 33710288 — intervention group
Group type: EXPERIMENTAL
Intervention: Active iTBS (120% resting motor threshold)
Number of subjects: 37
Study 33710288 — intervention group
Group type: COMPARATOR
Intervention: Sham iTBS
Number of subjects: 37
Study 33710288 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label iTBS (after double-blind phase)
Number of subjects: 37
Study 32546128 — intervention group
Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy (GVL)
Number of subjects: 65
Study 32546128 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 65
Study 32729280 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct access to hospitals for HCV-positive participants
Number of subjects: 351
Study 32729280 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 351
Study 32729280 — intervention group
Group type: EXPERIMENTAL
Intervention: PoC HCV screening with direct access referral
Number of subjects: 351
Study 33577181 — intervention group
Group type: EXPERIMENTAL
Intervention: Dye-based chromoendoscopy (CE)
Number of subjects: 533
Study 33577181 — intervention group
Group type: COMPARATOR
Intervention: White light endoscopy (WLE)
Number of subjects: 533
Study 32202163 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention with standard care plus 12 MI sessions within 12 weeks
Number of subjects: 25
Study 32202163 — intervention group
Group type: COMPARATOR
Intervention: Standard care only (Control)
Number of subjects: 25
Study 32202163 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention
Number of subjects: 25
Study 34537802 — intervention group
Group type: EXPERIMENTAL
Intervention: B100R (100% braking load reduction during landing with release at touchdown)
Number of subjects: 22
Study 34537802 — intervention group
Group type: COMPARATOR
Intervention: B0 (traditional load, no braking)
Number of subjects: 22
Study 34537802 — intervention group
Group type: EXPERIMENTAL
Intervention: B25 (25% braking load reduction during landing)
Number of subjects: 22
Study 34537802 — intervention group
Group type: EXPERIMENTAL
Intervention: B50 (50% braking load reduction during landing)
Number of subjects: 22
Study 33081705 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth Cognitive-Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 126
Study 33081705 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 126
Study 33081705 — intervention group
Group type: COMPARATOR
Intervention: Medication placebo
Number of subjects: 126
Study 35768092 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial pulse palpation
Number of subjects: 4339